PlainPharmaWatch

CMS Open Payments · Program Year 2024

Astellas Pharma Europe BV

Astellas Pharma Europe BV reported $12,007.60 across General Payments, Research, and Ownership to 2 physicians and teaching hospitals across 13 transactions.

See the rankings → How this is sourced
$12.0K
All-tracks total
13
Transactions
2
Recipients
#1615
of 1,925 companies

Astellas Pharma Europe BV reported $12,007.60 across all CMS Open Payments tracks (General + Research + Ownership) to 2 physicians and teaching hospitals in Program Year 2024 - ranking #1615 of 1,925 reporting manufacturers (0.0% of the all-tracks industry total); General Payments alone were $143.10, averaging $6.0K per recipient.

Data currency: Figures are rendered from the processed CMS Open Payments release. See our methodology for source dates and refresh cadence. Spot a figure that looks wrong? Report a correction.

Compiled from official public sources by the publisher.

CMS Sunshine Act warrant

Manufacturer astellas-pharma-europe-bv Astellas Pharma Europe BV

$12.0K · #1615/1,925 · 0.0% industry · PY2024

  • TOT $12.0K
  • RANK #1615
  • SHARE 0.0%
  • TXN 13
  • RCP 2
  • CAT 1
  • GEN $143.10
  • TOP1 50.0%
  • PY 2024

Volume peers

Nearest volume peer: Blue Surgical Llc ($12.0K)

Dutch Ophthalmic Research Ce…$12.1KAstellas Pharma Europe BV (t…$12.0KBlue Surgical Llc$12.0KPfizer S.a.$11.9KMusic City Medical Technolog…$11.8K
All-tracks payment totals near Astellas Pharma Europe BV (CMS Open Payments PY2024)

Astellas Pharma Europe BV sits among 1,925 manufacturers disclosing under the Physician Payments Sunshine Act. Volume peers below are nearest by all-tracks total, not corporate affiliates. Open the company rankings →

What the Data Shows for Astellas Pharma Europe BV

In Program Year 2024, Astellas Pharma Europe BV reported $12,007.60 in payments to 2 physicians and teaching hospitals across 13 individual transactions, an average of $923.66 per transaction and $6.0K per recipient. That total places Astellas Pharma Europe BV at rank #1615 out of 1,925 companies in the CMS Open Payments database, a comparatively small 0.0% slice of all industry payments reported nationwide for the year.

The 1-category breakdown below covers general payments only (see our methodology for how research and ownership payments are reported separately). The largest general-payment category is "Food and Beverage" at $143.10, accounting for 100.0% of this company's General Payments and 2 transactions.

General Payment Breakdown by Type

Astellas Pharma Europe BV made 1 types of general payments. "Food and Beverage" is the largest category at $143.10, 100.0% of General Payments.

How Astellas Pharma Europe BV divides its payments

General-payment categories, ordered by reported total

1. Food and Beverage$143.10
Payment Type Amount Transactions
Food and Beverage $143.10 2

Recipient Concentration in General Payments

The five largest recipient relationships account for $143.10 (100.0%) of $143.10 in this company's General Payments records across 2 recipients.

General Payments scope note

Program Year 2024 General Payments view only: excludes research and ownership/investment records, so it is not the all-category company total above.

Largest General-Payment relationships for Astellas Pharma Europe BV

The five named recipients with the highest reported General Payments from this company

Neal Shore$71.55Ana Aparicio$71.55
  1. 1

    Neal Shore

    $71.55 across 1 reported transactions

  2. 2

    Ana Aparicio

    $71.55 across 1 reported transactions

Compare this company's payment profile with similarly sized manufacturers in the company comparison tool, and consult the methodology for the CMS source scope.

Similarly Concentrated Companies

Companies whose General Payments are spread across recipients about as (un)evenly as Astellas Pharma Europe BV's, measured by the same HHI concentration index above, not by payment size.

What HHI 2,500 means here

2,500 is the DOJ/FTC merger-guidelines threshold for "highly concentrated" markets; used here only as a familiar concentration reference, not a legal finding about Astellas Pharma Europe BV.

Mobius Therapeutics, LLC

HHI 5000

SmartPractice Allergen Bank, L.L.C.

HHI 5000

LumiraDx, Inc.

HHI 5000

STORZ MEDICAL America, Inc.

HHI 5000

Companies with Similar Payment Volumes

Open a profile or compare a similar company's CMS-reported payment pattern with Astellas Pharma Europe BV.

Showing 6 of 1,924 companies with CMS-reported payment data.

Data Source: Centers for Medicare & Medicaid Services (CMS) Open Payments, Program Year 2024. Data includes general payments, research payments, and physician ownership/investment interests as required by the Physician Payments Sunshine Act. Total industry payments: $13.9B across 1,925 companies.

Data sourced from CMS Open Payments (Physician Payments Sunshine Act). See our methodology for details. Retrieved and formatted by PlainPharmaWatch
Disclaimer

This information is provided for informational purposes only and does not constitute professional advice. Data is sourced from the CMS Open Payments program. Consult a qualified professional before making decisions based on this data.

Read our methodology - how this data is sourced, computed, and verified.

View saved (companies)
Download Astellas Pharma Europe BV's data (CSV)
Embed this widget

Copy this snippet to embed a live-linked card on your own site.

Every figure on PlainPharmaWatch is rendered directly from federal source data, no number is typed in by an editor. This page draws directly on federal source data, no figure is typed in by an editor. See our editorial standards & corrections policy, the methodology behind these numbers, or report a data error. Data current as of 2026-07-26.